Towards Improved Oligonucleotide Therapeutics Through Faster Target Binding Kinetics.

Mirjam Menzi1, Bettina Wild1, Ugo Pradère1

  • 1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zürich, 8093, Zürich, Switzerland.

Summary

Researchers enhanced gene silencing oligonucleotides by conjugating spermine, significantly boosting their RNA binding affinity. This modification improves hybridization speed, offering potential for more effective gene expression inhibition in cellular applications.